Jacobson Pharma Corporation Limited (2633.HK)
- Previous Close
0.570 - Open
0.560 - Bid 0.560 x --
- Ask 0.570 x --
- Day's Range
0.560 - 0.560 - 52 Week Range
0.540 - 0.771 - Volume
22,000 - Avg. Volume
553,764 - Market Cap (intraday)
1.12B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
5.09 - EPS (TTM)
0.110 - Earnings Date --
- Forward Dividend & Yield 0.05 (8.77%)
- Ex-Dividend Date Dec 18, 2023
- 1y Target Est
--
Jacobson Pharma Corporation Limited, through its subsidiaries, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including the respiratory, cardiovascular, central nervous system, gastrointestinal, genito-urinary, musculoskeletal, endocrine and metabolic, dermatological, anti-allergics, scar treatment, oral anti-diabetics, and anti-infective, as well as arsenic trioxide oral solutions. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung, and Shiling oil, as well as Contractubex, Smartfish, Rowatanal, Oncotype DX, and AIM Atropine products. In addition, it engages in the trading of medical supplies; procurement of packaging materials; treasury services; sale of healthcare and herbal products; research and development; and property holding activities. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
www.jacobsonpharma.com1,588
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 2633.HK
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2633.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2633.HK
Valuation Measures
Market Cap
1.14B
Enterprise Value
1.59B
Trailing P/E
5.02
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.50
Enterprise Value/Revenue
0.83
Enterprise Value/EBITDA
3.87
Financial Highlights
Profitability and Income Statement
Profit Margin
14.02%
Return on Assets (ttm)
4.95%
Return on Equity (ttm)
10.92%
Revenue (ttm)
1.92B
Net Income Avi to Common (ttm)
244.99M
Diluted EPS (ttm)
0.110
Balance Sheet and Cash Flow
Total Cash (mrq)
911.18M
Total Debt/Equity (mrq)
57.38%
Levered Free Cash Flow (ttm)
361.38M